Cargando…

Patient-reported outcomes before and after treatment of major depressive disorder

Patient reported outcomes (PROs) of quality of life (QoL), functioning, and depressive symptom severity are important in assessing the burden of illness of major depressive disorder (MDD) and to evaluate the impact of treatment. We sought to provide a detailed analysis of PROs before and after treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	IsHak, Waguih William, Mirocha, James, Pi, Sarah, Tobia, Gabriel, Becker, Bret, Peselow, Eric D., Cohen, Robert M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Les Laboratoires Servier 2014
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140511/ https://www.ncbi.nlm.nih.gov/pubmed/25152656

Ejemplares similares

Examining the Impact of Patient-Reported Hope for Improvement and Patient Satisfaction with Clinician/Treatment on the Outcome of Major Depressive Disorder Treatment
por: IsHak, Waguih William, et al.
Publicado: (2016)

Personalized treatments for depressive symptoms in patients with advanced heart failure: A pragmatic randomized controlled trial
por: IsHak, Waguih William, et al.
Publicado: (2021)

NMDA antagonists for treating the non-motor symptoms in Parkinson’s disease
por: Vanle, Brigitte, et al.
Publicado: (2018)

Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder
por: Leuchter, Andrew F., et al.
Publicado: (2014)

Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder
por: Papakostas, George I., et al.
Publicado: (2008)

Hypothalamus-Anchored Resting Brain Network Changes before and after Sertraline Treatment in Major Depression
por: Yang, Rui, et al.
Publicado: (2014)

The impact of antidepressants on depressive symptom severity, quality of life, morbidity, and mortality in heart failure: a systematic review
por: Hedrick, Rebecca, et al.
Publicado: (2020)

Sex Differences in Intergenerational Transfer Risk of Major Depressive Disorder
por: Fang, Guoxiang, et al.
Publicado: (2019)

Altered Pituitary Gland Structure and Function in Posttraumatic Stress Disorder
por: Cooper, Odelia, et al.
Publicado: (2017)

Genetic evidence suggests posttraumatic stress disorder as a subtype of major depressive disorder
por: Zhang, Fuquan, et al.
Publicado: (2022)

Challenges in the development of clinical trials for major depressive disorder: lessons learned from trials in minor depression
por: Rapaport, Mark H., et al.
Publicado: (2002)

Effectiveness of trauma-focused treatment for adolescents with major depressive disorder
por: Paauw, Corine, et al.
Publicado: (2019)

Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study
por: Cassano, Paolo, et al.
Publicado: (2015)

Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations
por: Flory, Janine D., et al.
Publicado: (2015)

Association between AKT1 gene polymorphisms and depressive symptoms in the Chinese Han population with major depressive disorder★
por: Yang, Chunxia, et al.
Publicado: (2012)

Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder
por: Huang, Yichen, et al.
Publicado: (2018)

Epidemiology of treatment resistant depression among major depressive disorder patients in Israel
por: Sharman Moser, Sarah, et al.
Publicado: (2022)

Long Non-Coding RNA: Potential Diagnostic and Therapeutic Biomarker for Major Depressive Disorder
por: Cui, Xuelian, et al.
Publicado: (2016)

Cortisol in relation to problematic eating behaviours, adiposity and symptom profiles in Major Depressive Disorder
por: Mills, Jessica G., et al.
Publicado: (2021)

The comparison of severity and prevalence of major depressive disorder, general anxiety disorder and eating disorders before and after bariatric surgery
por: Matini, Diana, et al.
Publicado: (2014)

Predictors of Electroconvulsive Therapy Outcome in Major Depressive Disorder
por: Su, Liang, et al.
Publicado: (2022)

Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder
por: Wen, X.J., et al.
Publicado: (2014)

The norepinephrine transporter gene is associated with the retardation symptoms of major depressive disorder in the Han Chinese population★
por: Li, Xinrong, et al.
Publicado: (2012)

Hair-based biomarkers in women with major depressive disorder: Glucocorticoids, endocannabinoids, N-acylethanolamines, and testosterone
por: Behnke, Alexander, et al.
Publicado: (2021)

Characteristics, correlates, and outcomes of childhood and adolescent depressive disorders
por: Rao, Uma, et al.
Publicado: (2009)

Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies
por: Thase, Michael E.
Publicado: (2014)

Electroconvulsive Therapy-Induced Brain Structural and Functional Changes in Major Depressive Disorders: A Longitudinal Study
por: Qiu, Haitang, et al.
Publicado: (2016)

Cortical and subcortical gray matter alterations in first-episode drug-naïve adolescents with major depressive disorder
por: Kim, Ji Hyun, et al.
Publicado: (2019)

Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future
por: Fabbri, Chiara, et al.
Publicado: (2020)

Molecular pathways of major depressive disorder converge on the synapse
por: Fries, Gabriel R., et al.
Publicado: (2022)

Tumor Necrosis Factor-α Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment
por: Yao, Lin, et al.
Publicado: (2020)

The prevalence and incidence of major depressive disorder in 8079 Chinese university freshmen before and during COVID-19
por: Liu, Debiao, et al.
Publicado: (2022)

Double-Blinding and Bias in Medication and Cognitive-Behavioral Therapy Trials for Major Depressive Disorder
por: Berger, Douglas
Publicado: (2016)

Apparent dose-dependent levetiracetam-induced de novo major depression with suicidal behavior()()
por: Kaufman, Kenneth R., et al.
Publicado: (2013)

Distribution of microRNAs associated with major depressive disorder among blood compartments
por: Homorogan, Claudia, et al.
Publicado: (2021)

Temperament and major depressive disorder
por: Karam, Elie G, et al.
Publicado: (2010)

Neurobiology of Major Depressive Disorder
por: Villanueva, Rosa
Publicado: (2013)

Lipidomics in Major Depressive Disorder
por: Walther, Andreas, et al.
Publicado: (2018)

SUMOylation and Major Depressive Disorder
por: Jeoung, Seok-Won, et al.
Publicado: (2022)

Thyroid hormones association with depression severity and clinical outcome in patients with major depressive disorder
por: Berent, Dominika, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ar1lklh4tgc5ir2kk79u2fc5h3